 | • レポートコード：QY20ST-00098 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の特殊医薬品有効成分（API）市場について種類別（ステロイドAPI、ペプチドAPI、炭水化物API、低分子API、高効力AP）、用途別（CNS、循環器、泌尿生殖器/ホルモン剤、リウマチ、糖尿病、腫瘍学、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・特殊医薬品有効成分（API）市場の概要 ・世界の主要地域別特殊医薬品有効成分（API）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の特殊医薬品有効成分（API）市場規模2015-2026：種類別（ステロイドAPI、ペプチドAPI、炭水化物API、低分子API、高効力AP） ・世界の特殊医薬品有効成分（API）市場規模2015-2026：用途別（CNS、循環器、泌尿生殖器/ホルモン剤、リウマチ、糖尿病、腫瘍学、その他） ・特殊医薬品有効成分（API）の北米市場規模2015-2020 ・特殊医薬品有効成分（API）のヨーロッパ市場規模2015-2020 ・特殊医薬品有効成分（API）の中国市場規模2015-2020 ・特殊医薬品有効成分（API）の日本市場規模2015-2020 ・特殊医薬品有効成分（API）の東南アジア市場規模2015-2020 ・特殊医薬品有効成分（API）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・特殊医薬品有効成分（API）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・特殊医薬品有効成分（API）の市場動向・機会・課題 ・調査の結論 |
Special active pharmaceutical ingredients are bioactive chemicals used as intermediate components in pharmaceutical manufacturing, such as tablets, capsules, syrups, etc.Special active pharmaceutical ingredients include steroidal API, peptide, carbohydrate API, small molecule and high efficiency API.
Market Analysis and Insights: Global Specialty Active Pharmaceutical Ingredients Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Specialty Active Pharmaceutical Ingredients market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Specialty Active Pharmaceutical Ingredients industry.
Based on our recent survey, we have several different scenarios about the Specialty Active Pharmaceutical Ingredients YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Specialty Active Pharmaceutical Ingredients will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Specialty Active Pharmaceutical Ingredients Scope and Market Size
The global Specialty Active Pharmaceutical Ingredients market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Specialty Active Pharmaceutical Ingredients market is segmented into
Steroidal API
Peptide API
Carbohydrate API
Small Molecule API
High Potency AP
Segment by Application, the Specialty Active Pharmaceutical Ingredients market is segmented into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Rheumatology
Diabetes
Oncology
Others
The Specialty Active Pharmaceutical Ingredients market is analysed and market size information is provided by regions (countries). Segment by Application, the Specialty Active Pharmaceutical Ingredients market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Specialty Active Pharmaceutical Ingredients Market Share Analysis
Specialty Active Pharmaceutical Ingredients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Specialty Active Pharmaceutical Ingredients business, the date to enter into the Specialty Active Pharmaceutical Ingredients market, Specialty Active Pharmaceutical Ingredients product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Cambrex
Almac
Johnson Matthey
PolyPeptide
AmbioPharm
Avecia
ST Pharm
Biospring
1 Specialty Active Pharmaceutical Ingredients Market Overview
1.1 Specialty Active Pharmaceutical Ingredients Product Scope
1.2 Specialty Active Pharmaceutical Ingredients Segment by Type
1.2.1 Global Specialty Active Pharmaceutical Ingredients Sales by Type (2020-2026)
1.2.2 Steroidal API
1.2.3 Peptide API
1.2.4 Carbohydrate API
1.2.5 Small Molecule API
1.2.6 High Potency AP
1.3 Specialty Active Pharmaceutical Ingredients Segment by Application
1.3.1 Global Specialty Active Pharmaceutical Ingredients Sales Comparison by Application (2020-2026)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts (2015-2026)
1.4.1 Global Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2026)
1.4.2 Global Specialty Active Pharmaceutical Ingredients Revenue and Growth Rate (2015-2026)
1.4.3 Global Specialty Active Pharmaceutical Ingredients Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Specialty Active Pharmaceutical Ingredients Industry Impact
1.5.1 How the Covid-19 is Affecting the Specialty Active Pharmaceutical Ingredients Industry
1.5.1.1 Specialty Active Pharmaceutical Ingredients Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Specialty Active Pharmaceutical Ingredients Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Specialty Active Pharmaceutical Ingredients Players to Combat Covid-19 Impact
2 Specialty Active Pharmaceutical Ingredients Estimate and Forecast by Region
2.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
2.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
2.3 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Specialty Active Pharmaceutical Ingredients Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Specialty Active Pharmaceutical Ingredients Estimates and Projections (2015-2026)
2.4.2 Europe Specialty Active Pharmaceutical Ingredients Estimates and Projections (2015-2026)
2.4.3 China Specialty Active Pharmaceutical Ingredients Estimates and Projections (2015-2026)
2.4.4 Japan Specialty Active Pharmaceutical Ingredients Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Specialty Active Pharmaceutical Ingredients Estimates and Projections (2015-2026)
2.4.6 India Specialty Active Pharmaceutical Ingredients Estimates and Projections (2015-2026)
3 Global Specialty Active Pharmaceutical Ingredients Competition Landscape by Players
3.1 Global Top Specialty Active Pharmaceutical Ingredients Players by Sales (2015-2020)
3.2 Global Top Specialty Active Pharmaceutical Ingredients Players by Revenue (2015-2020)
3.3 Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2019)
3.4 Global Specialty Active Pharmaceutical Ingredients Average Price by Company (2015-2020)
3.5 Manufacturers Specialty Active Pharmaceutical Ingredients Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Specialty Active Pharmaceutical Ingredients Players (Opinion Leaders)
4 Global Specialty Active Pharmaceutical Ingredients Market Size by Type
4.1 Global Specialty Active Pharmaceutical Ingredients Historic Market Review by Type (2015-2020)
4.1.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
4.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2015-2020)
4.1.3 Global Specialty Active Pharmaceutical Ingredients Price by Type (2014-2020)
4.2 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026)
4.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026)
4.2.3 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Type (2021-2026)
5 Global Specialty Active Pharmaceutical Ingredients Market Size by Application
5.1 Global Specialty Active Pharmaceutical Ingredients Historic Market Review by Application (2015-2020)
5.1.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
5.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)
5.1.3 Global Specialty Active Pharmaceutical Ingredients Price by Application (2015-2020)
5.2 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026)
5.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026)
5.2.3 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2021-2026)
3 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures
3.2 North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
3.3 North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
3.4 North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
4 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures
4.2 Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
4.3 Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
4.4 Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
5 China Specialty Active Pharmaceutical Ingredients Market Facts & Figures
5.2 China Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
5.3 China Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
5.4 China Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
6 Japan Specialty Active Pharmaceutical Ingredients Market Facts & Figures
6.2 Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
6.3 Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
6.4 Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
7 Southeast Asia Specialty Active Pharmaceutical Ingredients Market Facts & Figures
7.2 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
8 India Specialty Active Pharmaceutical Ingredients Market Facts & Figures
8.2 India Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
8.3 India Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
8.4 India Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Specialty Active Pharmaceutical Ingredients Business
12.1 Sanofi
12.1.1 Sanofi Specialty Active Pharmaceutical Ingredients Corporation Information
12.1.2 Sanofi Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
12.1.5 Sanofi Recent Development
12.2 Cambrex
12.2.1 Cambrex Specialty Active Pharmaceutical Ingredients Corporation Information
12.2.2 Cambrex Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Products Offered
12.2.5 Cambrex Recent Development
12.3 Almac
12.3.1 Almac Specialty Active Pharmaceutical Ingredients Corporation Information
12.3.2 Almac Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.3.3 Almac Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Almac Specialty Active Pharmaceutical Ingredients Products Offered
12.3.5 Almac Recent Development
12.4 Johnson Matthey
12.4.1 Johnson Matthey Specialty Active Pharmaceutical Ingredients Corporation Information
12.4.2 Johnson Matthey Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Products Offered
12.4.5 Johnson Matthey Recent Development
12.5 PolyPeptide
12.5.1 PolyPeptide Specialty Active Pharmaceutical Ingredients Corporation Information
12.5.2 PolyPeptide Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Products Offered
12.5.5 PolyPeptide Recent Development
12.6 AmbioPharm
12.6.1 AmbioPharm Specialty Active Pharmaceutical Ingredients Corporation Information
12.6.2 AmbioPharm Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Products Offered
12.6.5 AmbioPharm Recent Development
12.7 Avecia
12.7.1 Avecia Specialty Active Pharmaceutical Ingredients Corporation Information
12.7.2 Avecia Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.7.3 Avecia Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Avecia Specialty Active Pharmaceutical Ingredients Products Offered
12.7.5 Avecia Recent Development
12.8 ST Pharm
12.8.1 ST Pharm Specialty Active Pharmaceutical Ingredients Corporation Information
12.8.2 ST Pharm Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Products Offered
12.8.5 ST Pharm Recent Development
12.9 Biospring
12.9.1 Biospring Specialty Active Pharmaceutical Ingredients Corporation Information
12.9.2 Biospring Specialty Active Pharmaceutical Ingredients Business Overview and Total Revenue
12.9.3 Biospring Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biospring Specialty Active Pharmaceutical Ingredients Products Offered
12.9.5 Biospring Recent Development
13 Specialty Active Pharmaceutical Ingredients Manufacturing Cost Analysis
13.1 Specialty Active Pharmaceutical Ingredients Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients
13.4 Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Specialty Active Pharmaceutical Ingredients Distributors List
14.3 Specialty Active Pharmaceutical Ingredients Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Specialty Active Pharmaceutical Ingredients Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Specialty Active Pharmaceutical Ingredients Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Specialty Active Pharmaceutical Ingredients Players to Combat Covid-19 Impact
Table 8. Global Market Specialty Active Pharmaceutical Ingredients Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Region (2015-2020)
Table 10. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Table 11. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Region (2015-2020)
Table 13. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Specialty Active Pharmaceutical Ingredients Revenue Share Forecast by Region (2021-2026)
Table 17. Global Specialty Active Pharmaceutical Ingredients (K MT) of Key Companies (2015-2020)
Table 18. Global Specialty Active Pharmaceutical Ingredients Sales Share by Company (2015-2020)
Table 19. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Company (2015-2020)
Table 21. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2019)
Table 22. Global Specialty Active Pharmaceutical Ingredients Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Specialty Active Pharmaceutical Ingredients Manufacturing Sites and Area Served
Table 24. Manufacturers Specialty Active Pharmaceutical Ingredients Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Specialty Active Pharmaceutical Ingredients Players
Table 27. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 28. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)
Table 29. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Specialty Active Pharmaceutical Ingredients Price (K MT) by Type (2015-2020)
Table 31. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2021-2026)
Table 32. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2021-2026)
Table 34. Global Specialty Active Pharmaceutical Ingredients Price (K MT) by Type (2021-2026)
Table 35. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)
Table 36. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2015-2020)
Table 37. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Specialty Active Pharmaceutical Ingredients Price (K MT) by Application (2015-2020)
Table 39. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2021-2026)
Table 40. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2021-2026)
Table 41. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Application (2021-2026)
Table 43. Global Specialty Active Pharmaceutical Ingredients Price (K MT) by Application (2021-2026)
Table 44. United States Specialty Active Pharmaceutical Ingredients Sales (K MT) by Company (2015-2020)
Table 45. United States Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
Table 46. United States Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 47. United States Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 48. United States Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)
Table 49. United States Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 50. Europe Specialty Active Pharmaceutical Ingredients Sales (K MT) by Company (2015-2020)
Table 51. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
Table 52. Europe Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 53. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 54. Europe Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)
Table 55. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 56. China Specialty Active Pharmaceutical Ingredients Sales (K MT) by Company (2015-2020)
Table 57. China Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
Table 58. China Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 59. China Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 60. China Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)
Table 61. China Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 62. Japan Specialty Active Pharmaceutical Ingredients Sales (K MT) by Company (2015-2020)
Table 63. Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
Table 64. Japan Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 65. Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 66. Japan Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)
Table 67. Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 74. India Specialty Active Pharmaceutical Ingredients Sales (K MT) by Company (2015-2020)
Table 75. India Specialty Active Pharmaceutical Ingredients Sales Market Share by Company (2015-2020)
Table 76. India Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 77. India Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 78. India Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)
Table 79. India Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi Specialty Active Pharmaceutical Ingredients Product
Table 84. Sanofi Recent Development
Table 85. Cambrex Corporation Information
Table 86. Cambrex Description and Business Overview
Table 87. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Cambrex Specialty Active Pharmaceutical Ingredients Product
Table 89. Cambrex Recent Development
Table 90. Almac Corporation Information
Table 91. Almac Description and Business Overview
Table 92. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Almac Specialty Active Pharmaceutical Ingredients Product
Table 94. Almac Recent Development
Table 95. Johnson Matthey Corporation Information
Table 96. Johnson Matthey Description and Business Overview
Table 97. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson Matthey Specialty Active Pharmaceutical Ingredients Product
Table 99. Johnson Matthey Recent Development
Table 100. PolyPeptide Corporation Information
Table 101. PolyPeptide Description and Business Overview
Table 102. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. PolyPeptide Specialty Active Pharmaceutical Ingredients Product
Table 104. PolyPeptide Recent Development
Table 105. AmbioPharm Corporation Information
Table 106. AmbioPharm Description and Business Overview
Table 107. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. AmbioPharm Specialty Active Pharmaceutical Ingredients Product
Table 109. AmbioPharm Recent Development
Table 110. Avecia Corporation Information
Table 111. Avecia Description and Business Overview
Table 112. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Avecia Specialty Active Pharmaceutical Ingredients Product
Table 114. Avecia Recent Development
Table 115. ST Pharm Corporation Information
Table 116. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. ST Pharm Description and Business Overview
Table 118. ST Pharm Specialty Active Pharmaceutical Ingredients Product
Table 119. ST Pharm Recent Development
Table . Biospring Corporation Information
Table . Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Biospring Description and Business Overview
Table . Biospring Specialty Active Pharmaceutical Ingredients Product
Table . Biospring Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Specialty Active Pharmaceutical Ingredients Distributors List
Table 128. Specialty Active Pharmaceutical Ingredients Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Specialty Active Pharmaceutical Ingredients Product Picture
Figure 2. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Specialty Active Pharmaceutical Ingredients Market Share by Application in 2020 & 2026
Figure 6. CNS Examples
Figure 7. Cardiovascular Examples
Figure 8. Genitourinary/Hormonal Drugs Examples
Figure 9. Rheumatology Examples
Figure 10. Diabetes Examples
Figure 11. Oncology Examples
Figure 12. Others Examples
Figure 13. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Growth Rate (2015-2026)
Figure 14. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) Growth Rate (2015-2026)
Figure 15. Global Specialty Active Pharmaceutical Ingredients Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 16. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region: 2015 VS 2020
Figure 17. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region: 2021 VS 2026
Figure 18. United States Specialty Active Pharmaceutical Ingredients Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. United States Specialty Active Pharmaceutical Ingredients Sales (K MT) Growth Rate (2015-2026)
Figure 20. Europe Specialty Active Pharmaceutical Ingredients Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Europe Specialty Active Pharmaceutical Ingredients Sales (Million USD) Growth Rate (2015-2026)
Figure 22. China Specialty Active Pharmaceutical Ingredients Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. China Specialty Active Pharmaceutical Ingredients Sales (Million USD) and Growth Rate (2015-2026)
Figure 24. Japan Specialty Active Pharmaceutical Ingredients Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Japan Specialty Active Pharmaceutical Ingredients Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Specialty Active Pharmaceutical Ingredients Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales (Million USD) Growth Rate (2015-2026)
Figure 28. India Specialty Active Pharmaceutical Ingredients Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. India Specialty Active Pharmaceutical Ingredients Sales (Million USD) Growth Rate (2015-2026)
Figure 30. Global 5 Largest Specialty Active Pharmaceutical Ingredients Players Market Share by Revenue in Specialty Active Pharmaceutical Ingredients 2015 & 2019
Figure 31. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)
Figure 33. Global Specialty Active Pharmaceutical Ingredients Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Application (2015-2020)
Figure 35. Global Specialty Active Pharmaceutical Ingredients Revenue Growth Rate by Application in 2015 & 2019
Figure 36. United States Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 37. United States Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 38. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Company in 2019
Figure 39. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 40. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 41. China Specialty Active Pharmaceutical Ingredients Sales Market Share by Company in 2019
Figure 42. China Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 43. China Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 44. Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Company in 2019
Figure 45. Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 46. Japan Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 47. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Company in 2019
Figure 48. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 49. Southeast Asia Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 50. India Specialty Active Pharmaceutical Ingredients Sales Market Share by Company in 2019
Figure 51. India Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 52. India Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 53. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cambrex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Almac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Avecia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. ST Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Biospring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Specialty Active Pharmaceutical Ingredients
Figure 64. Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients
Figure 65. Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
アンチエイジング有効成分の世界市場レポート2020 Anti-Aging Active Ingredients is the product which delay, stop or retard the aging process. Market Analysis and Insights: Global Anti Ageing Active Ingredients Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World He…- 特殊化粧品成分の世界市場レポート2020 A recently published report by QY Research titled Global Specialty Cosmetic Ingredients Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provi…
- 特殊食品成分の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Specialty Food Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 保湿成分の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Moisturizer Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 医薬品有効成分の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Active Pharmaceutical Ingredient market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.3% in the forecast period of 2020 to 2025 and will expected to reach USD 83030 million by 2025, from USD 65040 million in 2019. The Activ…